New Acting FDA head

According to this story, the new acting FDA head, Andrew von Eschenbach, wants the agency to speed up the timelines for introducing new technologies to patients. This is good news, sort of, as long as they don't bury/whitewash negative impacts of treatments. HT Dave Meleney